GENE ONLINE|News &
Opinion
Blog

Regulatory
Trials & Approvals EGFR
Erdafitinib Approval,a Bright Spot Amid the Troughs in Bladder Cancer Trials
2019-04-23
Trials & Approvals EGFR
Vizimpro bags EU approval for NSCLC treatment
2019-04-16
Trials & Approvals Anxiety
FDA Approves New Drug for Specific Treatment of Postpartum Depression
2019-03-21
Trials & Approvals Breast Cancer
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Trials & Approvals Breast Cancer
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Trials & Approvals Ovarian Cancer
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Trials & Approvals Antibody
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Trials & Approvals
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Trials & Approvals
European approval of Pembrolizumab for resected Stage III melanoma – KN-54 excerpts
2018-12-21
Trials & Approvals Autoimmune
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
Trials & Approvals Alanine Aminotransferase
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
Trials & Approvals Hepatocellular Carcinoma
New hepatocellular carcinoma approval for Pembrolizumab – KN-224
2018-11-14
Trials & Approvals Multiple Myeloma
Empliciti®(elotuzumab) combination – New IO approval for relapsed Multiple Myeloma
2018-11-09
Trials & Approvals Immunotherapy Drug
Next Gen IO update – early phase clinical trials of anti-TIGIT/LAG3 antibodies
2018-11-08
Trials & Approvals Lung Cancer
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
1 … 50 51 52 53
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top